NHP Retirement
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 812910 Pet Care (except Veterinary) Services
- Points of contact
-
- Cber Acquisition Liaison cbereacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration (FDA) is forecasting a new requirement for the retirement of three female baboons from the White Oak Animal Program (WOAP). These animals, which arrived at FDA from Southwest Primate Center between July 2019 and February 2020, have completed multiple FDA studies including research on B. pertussis, data logger surgery, and N. gonorrhea. The solicitation is estimated to release on May 1, 2026, with an anticipated award date of September 1, 2026.
The estimated award value for this contract ranges from $25,000 to $250,000. The three baboons are currently six years old, healthy, socially housed together, and exhibit excellent behavioral disposition. Inquiries regarding this opportunity should be directed to the FDA's contracting mailbox at cbereacquisitions@fda.hhs.gov, with the work to be performed at the White Oak Animal Program facility.
Forecast text
This is a proposal for the retirement of three female baboons from the White Oak Animal Program (WOAP). These animals arrived at FDA from Southwest Primate Center. Two arrived on 7/25/2019. One arrived on 2/13/2020. Multiple FDA studies were completed (2020 B. pertussis, 2021 Data Logger Surgery, 2022 B. pertussis, 2023 N. gonorrhea) with these animals. The animals are 6 years old and currently healthy. Initial attempts to transfer them to other facilities were unsuccessful. The animals were listed as available for biomedical research transfer on the NIH NHP Locator application without inquiry. The animals are socially housed in a trio together in the same enclosure. They are excellent behavioral disposition and general health.
Note: The vast majority of NHPs from the WOAP are transferred for on-going use in biomedical research. Approximately 60 NHPs were transferred for biomedical research per the FDA Placement Guidelines from WOAP in 2023. The three animals in this proposal are older and larger in part because of their use on multiple studies and for study requiring sexual maturity.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast